Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
1970-01-01 08:00
US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics
By Diane Bartz and Leroy Leo WASHINGTON (Reuters) -The U.S. Federal Trade Commission said on Tuesday it has filed a
1970-01-01 08:00
FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC
Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen's acquisition of Horizon
1970-01-01 08:00
FTC to block Amgen's deal to acquire Horizon Therapeutics - source
The US Federal Trade Commission (FTC) is expected to file a lawsuit as early as Tuesday to block
1970-01-01 08:00
FTC to Sue to Block Amgen’s Takeover of Horizon Therapeutics
The US Federal Trade Commission is expected to file a lawsuit Tuesday to block Amgen Inc.’s $27.8 billion
1970-01-01 08:00